Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2021 How Should Clinicians Respond if Patient HIV Denial Could Exacerbate Racial Health Inequities? Tim Lahey, MD, MMSc Deception’s justifiability might depend on clinicians’ commitment to solidarity and awareness of social determinants of patients’ vulnerability to HIV infection. AMA J Ethics. 2021;23(5):E382-387. doi: 10.1001/amajethics.2021.382. In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28. Case and Commentary Apr 2006 Changing the Rules in Times of Crisis: Do Desperate Times Allow Desperate Measures? Mona Loutfy, MD, MPH Clinical case examines the ethics of using an experimental drug in treating a patient who is dying from a SARS-like virus. Virtual Mentor. 2006;8(4):214-218. doi: 10.1001/virtualmentor.2006.8.4.ccas4-0604.
Case and Commentary May 2021 How Should Clinicians Respond if Patient HIV Denial Could Exacerbate Racial Health Inequities? Tim Lahey, MD, MMSc Deception’s justifiability might depend on clinicians’ commitment to solidarity and awareness of social determinants of patients’ vulnerability to HIV infection. AMA J Ethics. 2021;23(5):E382-387. doi: 10.1001/amajethics.2021.382.
In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28.
Case and Commentary Apr 2006 Changing the Rules in Times of Crisis: Do Desperate Times Allow Desperate Measures? Mona Loutfy, MD, MPH Clinical case examines the ethics of using an experimental drug in treating a patient who is dying from a SARS-like virus. Virtual Mentor. 2006;8(4):214-218. doi: 10.1001/virtualmentor.2006.8.4.ccas4-0604.